| Old | New | Differences | |
|---|---|---|---|
| 1 | - | General Assembly Substitute Bill No. 5906 | |
| 2 | - | January Session, 2013 *_____HB05906GL____031413____* | |
| 1 | + | General Assembly Committee Bill No. 5906 | |
| 2 | + | January Session, 2013 LCO No. 4153 | |
| 3 | + | *04153HB05906GL_* | |
| 4 | + | Referred to Committee on GENERAL LAW | |
| 5 | + | Introduced by: | |
| 6 | + | (GL) | |
| 3 | 7 | ||
| 4 | 8 | General Assembly | |
| 5 | 9 | ||
| 6 | - | ||
| 10 | + | Committee Bill No. 5906 | |
| 7 | 11 | ||
| 8 | 12 | January Session, 2013 | |
| 9 | 13 | ||
| 10 | - | *_____HB05906GL____031413____* | |
| 14 | + | LCO No. 4153 | |
| 15 | + | ||
| 16 | + | *04153HB05906GL_* | |
| 17 | + | ||
| 18 | + | Referred to Committee on GENERAL LAW | |
| 19 | + | ||
| 20 | + | Introduced by: | |
| 21 | + | ||
| 22 | + | (GL) | |
| 11 | 23 | ||
| 12 | 24 | AN ACT CONCERNING PRESCRIPTIONS FOR CONTROLLED SUBSTANCES AND USE OF THE CONNECTICUT PRESCRIPTION MONITORING AND REPORTING SYSTEM. | |
| 13 | 25 | ||
| 14 | 26 | Be it enacted by the Senate and House of Representatives in General Assembly convened: | |
| 15 | 27 | ||
| 16 | 28 | Section 1. Section 21a-317 of the general statutes is repealed and the following is substituted in lieu thereof (Effective January 1, 2014): | |
| 17 | 29 | ||
| 18 | - | Every practitioner who distributes, administers or dispenses any controlled substance or who proposes to engage in distributing, prescribing, administering or dispensing any controlled substance within this state shall (1) obtain a certificate of registration issued by the Commissioner of Consumer Protection in accordance with the provisions of this chapter, and (2) prior to distributing, prescribing, administering or dispensing any such controlled substance, review the electronic prescription drug monitoring program established pursuant to section | |
| 30 | + | Every practitioner who distributes, administers or dispenses any controlled substance or who proposes to engage in distributing, prescribing, administering or dispensing any controlled substance within this state shall (1) obtain a certificate of registration issued by the Commissioner of Consumer Protection in accordance with the provisions of this chapter, and (2) prior to distributing, prescribing, administering or dispensing any such controlled substance, review the electronic prescription drug monitoring program established pursuant to section 21-254 for the patient's previous history of controlled substance use, if any. | |
| 19 | 31 | ||
| 20 | 32 | ||
| 21 | 33 | ||
| 22 | 34 | ||
| 23 | 35 | This act shall take effect as follows and shall amend the following sections: | |
| 24 | 36 | Section 1 January 1, 2014 21a-317 | |
| 25 | 37 | ||
| 26 | 38 | This act shall take effect as follows and shall amend the following sections: | |
| 27 | 39 | ||
| 28 | 40 | Section 1 | |
| 29 | 41 | ||
| 30 | 42 | January 1, 2014 | |
| 31 | 43 | ||
| 32 | 44 | 21a-317 | |
| 33 | 45 | ||
| 34 | - | Statement of | |
| 46 | + | Statement of Purpose: | |
| 35 | 47 | ||
| 36 | - | In subdivision (2), "21-254" was changed to "21a-254" for accuracy. | |
| 48 | + | To ensure health care practitioners are aware of patients' histories of controlled drug use prior to prescribing controlled substances. | |
| 49 | + | ||
| 50 | + | [Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.] | |
| 37 | 51 | ||
| 38 | 52 | ||
| 39 | 53 | ||
| 40 | - | ||
| 54 | + | Co-Sponsors: REP. NAFIS, 27th Dist.; SEN. DOYLE, 9th Dist. SEN. WITKOS, 8th Dist. | |
| 41 | 55 | ||
| 42 | - | ||
| 56 | + | Co-Sponsors: | |
| 43 | 57 | ||
| 44 | - | Joint Favorable Subst. -LCO | |
| 58 | + | REP. NAFIS, 27th Dist.; SEN. DOYLE, 9th Dist. | |
| 59 | + | ||
| 60 | + | SEN. WITKOS, 8th Dist. | |
| 61 | + | ||
| 62 | + | H.B. 5906 |